Blue Eagle Lithium
High Times
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Focalin sales are steady

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
fred198484 Member Profile
 
Followed By 2
Posts 437
Boards Moderated 0
Alias Born 07/13/16
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/23/2018 2:08:08 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/23/2018 2:04:30 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/18/2018 5:20:51 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/17/2018 2:54:24 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/17/2018 6:06:31 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/16/2018 5:31:22 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/16/2018 5:29:03 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2018 5:28:49 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/15/2018 3:52:11 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/15/2018 3:51:43 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 10/15/2018 7:35:39 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/12/2018 4:51:41 PM
Registration of Additional Securities (up to 20%, Foreign Issuer) (f-1mef) Edgar (US Regulatory) - 10/12/2018 6:08:11 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/12/2018 6:07:52 AM
Securities Registration (foreign Private Issuer) (f-1/a) Edgar (US Regulatory) - 10/11/2018 6:42:39 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/11/2018 6:36:13 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2018 6:06:49 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 10/5/2018 5:43:55 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/5/2018 7:16:25 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/5/2018 7:08:59 AM
Securities Registration (foreign Private Issuer) (f-1/a) Edgar (US Regulatory) - 10/5/2018 6:19:33 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/1/2018 8:12:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/1/2018 8:06:15 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/21/2018 4:43:58 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/21/2018 4:35:33 PM
fred198484   Friday, 11/10/17 11:52:02 AM
Re: None
Post # of 37567 
Focalin sales are steady


Bloomberg Intelligence: Molecule Detail
Molecule DEXMETHYLPHENIDATE HCL
View TRX Count By Payment Type By Week

PAR PHARMA

Payment Type 11/03/2017 10/27/2017 10/20/2017 10/13/2017 10/06/2017 09/29/201

Total 6.21k 6.28k 6.16k 6.10k 5.98k 6.20

Source: Symphony Health Solutions 



Bloomberg Intelligence: Molecule Detail
Molecule DEXMETHYLPHENIDATE HCL
View TRX Dollars By Payment Type By Week

PAR PHARMA

Payment Type 11/03/2017 10/27/2017 10/20/2017 10/13/2017 10/06/2017 09/29/201

Total 1.65M 1.68M 1.64M 1.62M 1.58M 1.63

Source: Symphony Health Solutions 


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist